Morcellators

BOWA Morcellator ERGO 300 Tissue Morcellation System

The BOWA Morcellator ERGO 300 is a powerful, precise and ergonomic tissue morcellation system designed for laparoscopic gynaecological procedures, including hysterectomy and myomectomy. It supports controlled morcellation and extraction of benign tissue during minimally invasive surgery, helping clinicians avoid larger abdominal incisions while maintaining surgical control and workflow efficiency.

The ERGO 300 is designed for accuracy, flexibility and ergonomic handling. It allows surgeons to select an appropriate working diameter depending on the surgical requirement. Common application sets include 12 mm and 15 mm, while availability of 20 mm configurations should be confirmed before ordering.

When used together with suitable containment solutions such as BOWA MetraBag and MetraLOOP, the ERGO 300 can form part of an enclosed morcellation workflow. This supports controlled in-bag morcellation and helps reduce the risk of tissue dispersion during laparoscopic hysterectomy and myomectomy.

Key Features

• Powerful morcellation system for laparoscopic gynaecological surgery
• Suitable for hysterectomy and myomectomy procedures
• Designed for precise, ergonomic and flexible tissue morcellation
• Supports minimally invasive tissue extraction
• Variable cutting speed control for procedural flexibility
• Foot switch operation for controlled hands-free use
• Common application sets include 12 mm and 15 mm working diameters
• 20 mm configuration should be confirmed before ordering
• Designed for controlled instrument insertion and handling
• Reusable system concept depending on selected components
• Compatible with enclosed morcellation workflows using suitable containment systems
• Can be used with BOWA MetraBag and MetraLOOP as part of a complete morcellation solution

Product Overview

Important Note

Morcellation should only be performed by trained clinicians and in accordance with local clinical guidance, patient selection protocols and hospital policy. Containment systems may help reduce tissue dispersion risk, but they do not remove all clinical risk. Final suitability must be assessed by the responsible surgical team.